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Abstract
Background: Polybrominated diphenyl ethers are known endocrine disrupting environmental contaminants used
as flame retardants. Their levels have increased in humans over the last ten years, raising concerns about their
consequences on human health. Some animal studies suggest that PBDEs can affect fetal growth; however, the
results of human studies are contradictory. This study evaluates the association between the most common PBDEs
in maternal blood measured in early pregnancy and birth weight.
Methods: BDE-47, BDE-99, BDE-100 and BDE-153 levels were measured in 349 women during their first prenatal care
visit at the University Hospital Center of Sherbrooke (Quebec, Canada). Birth weight and relevant medical information
were collected from medical records. In contrast with previous studies, we examined the full range of clinical risk
factors known to affect fetal growth as potential confounders, as well as other environmental pollutants that are likely
to interact with fetal growth (polychlorinated biphenyls (PCBs), mercury, lead, cadmium and manganese).
Results: There was no statistically significant relationship between PBDE levels in early pregnancy and birth weight in
both unadjusted and multivariate regression models.
Conclusions: Our results suggest that PBDEs in early pregnancy have little or no direct impact on birth weight, at least
at the levels of exposure in our population.
Keywords: Polybrominated diphenyl ethers, Pregnancy, Birth weight, Polychlorinated biphenyls, Mercury, Lead,
Cadmium, Manganese
Background
Polybrominated diphenyls ethers (PBDEs), are ubiqui-
tous environmental contaminants widely used as flame-
retardants in many consumer products (polyurethane
foams used in furniture, mattresses, carpet pads and
automobile seats and styrene plastics used for electrical
appliances and flame-retardant textiles) [1]. PBDEs have
been the focus of research over the past decade due to
their ubiquitous presence in the environment [2, 3] and
the human body (adipose tissue, blood, and breast milk)
[3] in addition to their endocrine disrupting properties
[4]. Furthermore, they are lipophilic compounds which
easily cross the placental barrier.
Several reports, including ours [5, 6], indicate that
PBDEs are thyroid disruptors in animals and humans,
and a few studies suggest that PBDEs may potentially
disrupt the insulin-like growth factor (IGF) system,
which is an anabolic stimulus of fetal growth [7]. Indeed,
uterine expression of insulin-like growth factor 1 (IGF-1)
was upregulated in adult rat offspring exposed prenatally
to 1 mg/(kg day) of BDE-99 [8]. Another study found that
perinatal exposure to 0.002 – 0.2 mg BDE-47/kg increased
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body weight in all Wistar rat offspring, accompanied by
increased plasma IGF-1 and glucose uptake in males (but
not in females) [9]. To our knowledge, only two studies
have examined the relationship between the IGF system
and PBDEs in humans. The first study found a positive
association between breast milk BDE-196 and IGF-1 in
the cord blood from 149 women in the general Taiwanese
population but they also found a negative association for
BDE-99 and 86 [10]. The second study suggested a posi-
tive correlation between umbilical cord serum PBDE
levels and placental gene expression of insulin-like growth
factor binding protein 3 (IGFBP-3) among Chinese chil-
dren living in one of the world’s largest electronic waste
sites [11].
We hypothesized that, through their interaction with the
IGF system, PBDEs could influence BW. Considering the
role of IGF-1 and IGFBP-3 in the regulation of fetal growth
[12], a positive association between prenatal exposure to
PBDEs and these hormones may lead to a positive associ-
ation between PBDEs and BW. However, among the
nine epidemiological studies assessing the relation be-
tween PBDEs and BW (see Table 1), four studies reported
a significant, negative association [13–16], two studies
reported a non significant, negative association [17, 18],
two others reported no statistically significant association
[19, 20], and one study suggested a negative association
for male infants and a positive association for female [21].
However, these epidemiological findings (i) were based on
designs differing from each other and from our study,
(ii) did not consider other ubiquitous environmental
pollutants which could also affect fetal growth and
(iii) did not take into account the relationship between
BW and gestational age.
The present study examines the association between
PBDEs in early pregnancy and BW in our prospective
birth cohort, GESTE (GEStation Thyroid and Environ-
ment), which has been specifically designed to study
health outcomes related to PBDE exposure in pregnant
women and their children. We focus on the most preva-
lent PBDE congeners in maternal and umbilical-cord
blood, which are BDE-47, BDE-99, BDE-100, and BDE-153
[14, 22–24]. Because PCBs are suspected to be associated
with BW (particularly CB-153, which was consistently
shown to be negatively associated with BW [21]), we ana-
lyzed the most prevalent PCBs in our samples as potential
confounding factors, as well as metals (mercury, lead, cad-
mium, and manganese), which are also ubiquitous in the
environment and have been reported to have an impact on
fetal growth [25–30].
Methods
Population recruitment
In the GESTE cohort, we recruited pregnant women at
their first prenatal visit (mean gestational age = 12 weeks,
SD = 2.96 weeks). As previously described [6], 400 eli-
gible women who agreed to participate at their first
prenatal care visit at the Research Center of the CHUS
(Centre Hospitalier Universitaire de Sherbrooke) in Quebec,
Canada, between September 2007 and December 2008,
were included. Virtually all pregnant women living in the
region served by the CHUS are seen in early pregnancy for
routine clinical tests including blood and urine sampling.
Eligibility criteria were maternal age (≥18 years), gestational
age < 20 weeks, and no known thyroid disease. Given our
intention to follow children from recruited pregnancies, we
excluded women who planned to move out of the region
in the following three years. Gestational age was confirmed
by ultrasonography. For this paper, four pregnancies for
which gestational age was found to be > 20 weeks based on
ultrasonography were kept in our analyses. We estimate
the rate of refusal to participate to be less than 5 % for
eligible women approached by members of the research
team. Maternal blood was collected at recruitment in
Table 1 Characteristics of 349 mothers-newborn in GESTE study,
Quebec, Canada, 2007–2008
Characteristics (range and unit) Mean (SD)
No (%)
Total population 349 (100)
Newborn characteristics
Male 179 (51.3)
Birth weight (1,555 to 4,705 g) 3,366.6 (504.1)
Low birth weight (BW < 2500 g) 16 (4.6)
Gestational age at recruitment (3.3 to 28.6 weeks
of amenorrhea)
11.01 (2.9)
Gestational age at birth (30.3 to 42.3 weeks of
amenorrhea)
39.3 (1.6)
Prematurity (Gestational age at birth < 37 weeks
of amenorrhea)
23 (6.6)
Maternal characteristics
Age at delivery (18 to 40 years) 28.8 (4.4)
Married or common-law relationship 323 (93)
BMI at recruitment (16.4 to 48.9 kg/m2) 25.9 (5.9)
Smoked during pregnancy 65 (19)
Alcohol consumption during pregnancy 19 (5.4)
Recreational drug consumption during pregnancy 5 (1.4)
Infection during pregnancy 32 (9)
Previous low birth weight (<2500 g) infant in
multipara (n = 236)
28 (12)
Previous preterm infant in multipara (n = 236) 16 (7)
Inter pregnancy intervala
Low (<18 months) 57 (24.3)
≥18 and ≤ 60 months 147 (62.5)
Large (>60 months) 31 (13.2)
Abbreviation: SD standard deviation
aTime interval between pregnancy before and GESTE pregnancy
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10-mL Vacutainer Hemogard tubes with ethylenedi-
aminetetraacetic acid (Becton-Dickinson, San Jose,
California). The plasma was frozen at −20 °C in
decontaminated Supelco glass storage tubes (Supelco,
Inc., Bellefonte, Pennsylvania) for PBDEs, PCBs and
thyroid hormone dosing. Blood was also obtained in
10-mL metal-free blood collection tubes with 0.05 mL of
15 % ethylenediaminetetraacetic acid K3 and stored at 4 °C
for manganese, lead, mercury and cadmium analysis.
The study protocol was approved by the Human Re-
search Ethics Committee of the CHUS, and an informed
consent form was signed by each participant.
Data collection
Outcome measurement
Information on BW was obtained from medical records
completed at delivery by the obstetrical team who weighed
newborns with a Scale-tronix pediatrics scale 4802.
Laboratory analysis
PBDE and PCB levels Plasma levels of PBDEs (BDE-47,
BDE-99, BDE-100, and BDE-153) and PCBs (CB-138, CB-
153, and CB-180) were analyzed in our laboratory based
on the method described by Covaci and Voorspoels [31].
Quality control was conducted through regular analyses
of water blanks added at every 10th sample, solvent
blanks, and random duplicate samples. All blanks were
subtracted from sample values on a batch basis. Interbatch
coefficients of variation were ≤10 % and ≤8 % for PBDEs
and PCBs, respectively. Limits of detection (LOD), defined
as 3 times the noise level, were established at 0.1 pg/μL
for PBDEs and at 0.02 pg/μL for PCBs. Routine checks of
accuracy and precision were also performed using refer-
ence materials (1589a) from the National Institute of
Standards and Technology (Gaithersburg, MD, USA). Re-
coveries ranged between 75 and 125 %. Here, we used the
sums of PBDE and PCB levels across classes, as well as
the levels of individual PBDEs and PCBs.
Metal levels Whole blood manganese, lead, cadmium
and mercury level determinations were performed by
the Toxicology Center of Quebec at the Quebec Institute
for Public Health (CTQ-INSPQ). Cold vapor atomic ab-
sorption spectrophotometry was used for total blood
mercury and mass spectrometry plasma torch (ICP-MS)
for lead, cadmium and manganese.
Limits of detection were 2.07 μg/L for lead, 0.1 μg/L
for mercury, 0.05 μg/L for cadmium, and 4.4 μg/L for
manganese.
Other relevant information
Following inclusion, women answered a questionnaire
administered by a research nurse who also measured
women’s height and weight. The questionnaire was used
to obtain women’s birth dates, education, marital status,
income, obstetrical history, smoking habits, consumption
of alcohol and recreational drugs. Another questionnaire
was administered after delivery by phone to complete data
for the period between recruitment and delivery. Preg-
nancy follow-up data (infection during pregnancy, BW
and baby sex) were also extracted from medical records
and gestational ages at recruitment and birth were calcu-
lated from the ultrasonography (see Additional file 1:
Table S1 for details).
Statistical analysis
All analyses were performed with SAS/STAT software
(SAS version 9.3) [32]. PBDE levels were analyzed in 386
of 400 participants due to the loss of 11 samples as a
result of analytical problems and the exclusion of twin
pregnancies (n = 3) post-hoc, for a total of 14 samples.
Additional losses to follow-up included 27 women with
miscarriages, 5 with voluntary abortions and 5 who de-
livered in another hospital. Our analyses were therefore
run on 349 newborn-mother pairs.
Analyses were conducted as follows: 1) Descriptive
statistics on exposure data, BW, and potential confound-
ing factors or modifiers were calculated. 2) Bi-variate
Spearman correlation analysis was performed to deter-
mine potential colinearities between contaminants, BW
and blood sampling time (gestational age at recruitment).
3) Simple and multivariate linear regressions were carried
out to study the association between BW and PBDEs.
A major challenge for a study of this nature is the lack
of empirical or biological basis for choosing among an
excessively large number of potential model specifications.
In particular, covariates and confounders are problematic,
given that many potentially important variables have not
been measured in previous studies, and that the evidence
on causal pathways necessary for constructing a directed
acyclic graph is largely absent. Additionally, BW and
gestational age are closely, non-linearly associated, and we
are not able to confirm if PBDEs could act on either
gestational duration as suggested in one preceding study
[33] or on growth rates, creating a collider bias in estimat-
ing the association between PBDE and BW if adjusted on
gestational age [34]. In addition, given that lipophilic
pollutants, such as PCBs (and PBDEs) are bound to blood
lipids [35, 36], the metabolism of which is rapidly chan-
ging in early pregnancy [37], we need to consider different
types of multivariate modeling to take into account
possible causal pathways.
To find the most relevant multiple regression models,
we first tested the relationship between BW and (i) other
pollutants (PCBs, cadmium, lead, mercury, manganese),
(ii) potential confounders or modifiers, which have been
extensively reviewed and shown to be moderately or
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strongly associated with low BW by the Institute of Health
Economics (IHE) [38]. These potential confounders were:
gestational age at birth, mother’s age at delivery, marital
status (single or not), Body Mass Index (BMI) at recruit-
ment, infection, smoking status, alcohol and recreational
drug consumption during pregnancy, and inter-pregnancy
interval. We have also tested infant sex and gestational
age at recruitment as potential covariates [39]. Since a
previous study found a different association between
PBDEs and IGF-1 according to sex [9], we also tested the
statistical interaction between sex and PBDE levels. Since
this interaction was not significant, these data are not
shown.
Our initial models were simple linear regression be-
tween PBDEs and BW. Covariates were included in mul-
tiple linear regression models if they were associated in
bivariate analyses with one PBDE congener or the sum
of PBDE and BW at P < 0.25. The following variables
were included in final multivariate models: mother’s age,
marital status, BMI, infections, smoking, PCBs, and lead
levels. We used the sum of PCBs (CB-138, 153, 180) in
our analyses as they were inter-correlated (Table 3).
Dependent variable
Gestational age was the most correlated with BW (r =
0.53, p < 0.001). To avoid collider bias [34], we created a
dependent variable “BW corrected for gestational age”,
which was used in all subsequent statistical models. The
correction of BW was done using residues from non-
parametric regression “SAS PROC LOESS” with 0.75 as
the smoothing parameter (see Additional file 1: Figure S1),
as follows:
We choose this procedure because the inter-quartile
interval of residues in this model was smaller com-
pared with linear, spline or curviline regression. The
obtained residuals were normally distributed (p-value
for Kolmogorov-Smirnov > 0.25).
Independent variable related to PBDE exposure
Among the 349 samples, 5 %, 23 % and 21 % (Table 2)
were below the limit of detection (LOD), which were
for BDE-99 (LOD = 0.001 ng/mL), BDE-100 (LOD =
0.001 ng/mL) and BDE-153 (LOD = 0.0006 ng/mL),
respectively. We ran linear regression analysis using
PBDEs congener individually by replacing below-LOD
values by LOD/2. To create the summed values (ΣPBDEs
and ΣPCBs), values below the limit of detection we used
zero for undetectable congeners.
Each PBDE congener was introduced in regression
models separately to avoid potential colinearity. In addition,
we used the sum of PBDEs as commonly used in the lit-
erature in order to compare our results with previous
studies. We have verified that for all models, residuals
were normally distributed (p-value for Kolmogorov-
Smirnov test > 5 %).
For each congener, we ran both: (i) volume-based
models where total plasma lipid levels were introduced
as an independent variable, and (ii) lipid-based models
where PBDEs were expressed in ng/g lipids.
Underlying distributions of PBDE congeners appeared
to be log-normal, so log10 transformation improved nor-
mality. Thus, we ran regression models using (i) PBDEs
non transformed concentrations and (ii) log10-transformed
PBDEs. In the results section, we only present the results
with PBDEs log10-transformed. Results with non trans-
formed PBDEs are presented in Additional file 1: Table S3.
Results
Socio-demographic information, lifestyle habits, BMI at
recruitment, obstetric history and pregnancy outcomes
are presented in Table 1. The majority of women were
married or in a common-law relationship (93 %) and
68 % were multiparous. Among multiparous women
12 % and 7 % had a history of low birth weight or pre-
mature delivery, respectively. The time interval between
their last delivery and the current pregnancy ranged
between 18 and 60 months for 63 %, less than 18 months
for 24 % and more than 60 months for 13 % of multipar-
ous women. Regarding mothers’ lifestyle factors, 19 %
reported being active cigarette smokers (the number of
cigarettes per day ranged from one to 20 in the first
trimester and from one to 15 in both the second and
third trimesters), 5 % to having consumed alcohol at
least once and 1 % to having used recreational drugs
during pregnancy. At recruitment, the women ranged
from 18 to 40 years old with an average age of 28 years.
Their BMI was between 16 to 49 Kg/m2 at inclusion
(average of 26 Kg/m2). Fifty-one percent of babies were
male, sixteen babies (4.6 %) weighed less than 2500 g at
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birth and 23 (6.6 %) were born prematurely (gestational
age < 37 weeks).
PBDE, PCB and metal levels are shown in Table 2 and
their inter-correlations are shown in Table 3. CB-138, 153
and 180 were detected respectively in 93 %, 99 % and
100 % of the samples. PBDE levels were inter-correlated
among congeners, but not all correlations were strong,
and were generally weaker than among PCB congeners.
Lead, cadmium and manganese were detected in all ma-
ternal samples. Manganese levels ranged between 4.4 and
32.45 μg/L. Mercury was detected in 85 % of cases in
concentrations ranging from 0.1 to 6.8 μg/L. Among
metals, inter-correlations ranged between −0.07 and 0.31.
The results of simple linear regression between BW
and potential confounders are detailed in Additional file 1:
Table S2. Gestational age at birth, sex, infection, smoking
during pregnancy and maternal pre-pregnancy BMI, ma-
ternal blood levels of cadmium were significantly asso-
ciated with BW at p < 0.05. In these relationships,
gestational age at birth explained 28 % and sex 2 % of
BW variance. The variance explained by other con-
founders ranged from 0.4 % for inter-pregnancy interval
to 2 % for maternal BMI at recruitment and maternal
infection during pregnancy. Early pregnancy levels of
cadmium explained 1 % and PCBs explained 0.8 % of
BW variance, respectively.
Table 4 shows the results of linear regression models
for PBDEs (each congener and the sum) in early preg-
nancy (expressed in ng/g of lipid and log10-transformed)
in relation to BW corrected for gestational age. PBDEs
were not significantly associated with BW corrected for
gestational age in both adjusted and unadjusted linear
regression. Furthermore, all these associations remained
non-significant in linear regressions adjusted for con-
founding factors. Interactions between sex and PBDEs
were never statistically significant (data not shown).
In sensitivity analyses we excluded neonates born before
the 37th week of gestation but the model estimates did not
change substantially. We also conducted the same ana-
lyzes excluding subjects with BDE-99, BDE-100, or BDE-
153 below LOD, but did not observe any change in the
results.
Discussion
We found no statistically significant association between
BW and levels of BDE-47, BDE-99, BDE-100, BDE-153
Table 2 Levels of PBDEs, PCBs, selenium, mercury, lead, cadmium and manganese in early pregnancy (N = 349)
% of detected values 25th percentile 50th percentile 75th percentile Maximum
PBDE congeners (ng/mL)
PBDE-47 100 0.07 0.12 0.25 2.74
PBDE-99 95 5.10−3 0.01 0.03 0.48
PBDE-100 77 4.10−3 7.10−3 0.01 0.36
PBDE-153 79 8.10−3 0.02 0.05 0.39
Σ PBDEs 0.10 0.19 0.34 3.63
PBDE congeners (ng/g of lipids)
PBDE-47 10.78 21.23 40.82 548.00
PBDE-99 0.76 1.93 5.44 96.00
PBDE-100 0.66 1.32 2.44 81.63
PBDE-153 1.08 2.44 8.97 85.33
Σ PBDEs 17.08 32.99 59.63 726.00
PCBs (ng/g of lipid)a
PCB-138 93 2.29 4.25 10.41 178.04
PCB-153 99 4.55 8.02 19.80 410.43
PCB-180 100 2.02 4.11 9.02 90.91
Σ PCBs 10.91 18.87 42.80 455.78
Metalsb
Manganese (ng/mL) 100 7.70 9.35 11.55 32.45
Mercury (ng/mL) 85 0.38 0.62 1.01 6.83
Lead (ng/mL) 100 6.21 8.28 10.35 64.17
Cadmium (ng/mL) 100 0.11 0.22 0.36 6.04
Abbreviations: PBDE(s) polybrominated diphenyl ether(s), ΣPBDE total PBDEs, PCB(s) polychlorinated biphenyl(s), ΣPCBs total PCBs
aMissing values for PCBs, n = 2
bMissing value for at least one metal (n = 57)
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and their sum. The absolute values of the slopes in re-
gressions vary between 0.8 and 70.4 g of BW, suggesting
a tiny clinical effect for a 10 fold increase in the concen-
tration of PBDEs. These findings remained unchanged in
both volume-based and lipid-based models.
Our study has the following methodological strengths
(i) a large sample size, (ii) extensive measurement of
known clinical and lifestyle risk factors for intrauterine
growth restriction and measured levels of other environ-
mental exposures (cadmium, manganese, lead, PBCs, and
mercury), which have been reported to be negatively
correlated with BW in the general population [25–30],
(iii) replication of results across a wide range of modeling
approaches, given the weak a priori knowledge available to
support model construction; and (iv) the use of BW
independently of its association with gestational age.
One of potential limitations of our study is that two
PBDE congeners (BDE-100 and BDE-153) were undetect-
able in 23 % and 21 % of the samples, respectively. In our
statistical analyses we considered them as LOD/2, which
might induce an under or overestimation of regression
slopes. However, we conducted sensitivity analyses, in
which we excluded undetectable data and we obtained
similar results.
Our population is representative of Canadian pregnant
women for blood metal levels, maternal age and birth
weight [40]. However, a greater proportion of the preg-
nant women in our study were smokers (19 %) com-
pared to Canadian pregnant women (15 %) [41]. Alcohol
consumption reported by the pregnant women in our
study group (5 %) is lower than in Canada (15 %) and
significantly lower compared to the rest of the Quebec
province (26 %) [42]. High education levels in our study
group was higher compared to pregnant women in
Canada [42], which could be partly related to our inclu-
sion criteria as well to the specificity of our recruitment
area (Sherbrooke has two Universities and two regional
Colleges). Median family income (CAD$60,000) was simi-
lar compared to women in Quebec in 2009 (CAD$64,000)
[42]. An additional difference consists of the fact that the
absolute majority of pregnant women were Caucasian (of
French or Irish origin), which reflects an historical par-
ticularity of our area. Globally, our study group was more
educated and more genetically homogenous, but similar
to Canadians in terms of environmental exposures and
birth weight. We believe that the high homogeneity of our
study group represents an advantage for testing the effects
of environmental exposures, because this situation is
closer to a quasi-experimental design.
In Table 5, we summarized all available epidemiological
data (9 publications) on PBDEs and BW. Four of them
reported a negative association between PBDE levels in
mothers and BW [13–16]. Harley et al. [13] found a sig-
nificant negative correlation between PBDE levels in the
second trimester and BW among 289 low income preg-
nant women who were also highly exposed to pesticides
in California. In another study in Ontario, Canada [14],
only BDE-99 in cord blood was negatively correlated with
Table 3 Spearman correlation coefficients for PBDEs, PCBs, mercury, lead, cadmium, manganese levels, birth weight and gestational
age at recruitment (N = 349)
BW GAR Cadmium Manganese Mercury Lead Sum of
PBDEs
BDE-47 BDE-99 BDE-100 BDE-153 Sum of
PCBs
CB-138 CB-153
BW -
GAR −0.03 -
Cadmium −0.12* 0.02 -
Manganese 0.05 −0.06 −0.07 -
HgT −0.01 −0.02 0.07 0.31*** -
Lead −0.10 −0.01 0.24*** 0.25*** 0.17** -
Sum of PBDEs 0.03 0.05 −0.03 0.00 0.04 −0.02 -
BDE-47 0.05 0.08 −0.03 −0.01 0.04 −0.04 0.95*** -
BDE-99 0.06 −0.004 −0.02 0.00 0.01 −0.03 0.73*** 0.58*** -
BDE-100 0.02 0.06 −0.04 0.03 0.00 0.06 0.28*** 0.11 0.19** -
BDE-153 −0.09 −0.09 0.01 0.01 0.00 0.10 0.53*** 0.32*** 0.54*** 0.14* -
Sum of PCBs 0.08 0.12* −0.08 0.12* 0.06 0.08 0.26*** 0.26*** 0.22*** 0.09 0.12* -
CB-138 0.10* 0.10* −0.05 0.08 0.03 0.04 0.12* 0.13* 0.08 0.09 0.06 0.76*** -
CB-153 0.05 0.09 −0.06 0.14* 0.06 0.05 0.31*** 0.32*** 0.25*** 0.06*** 0.09 0.84*** 0.39 -
CB-180 0.046 0.09 −0.06 0.03 0.04 0.12* 0.13* 0.12* 0.17** 0.06 0.17** 0.75*** 0.49*** 0.46***
All contaminants were expressed in ng/mL and below-LOD values were excluded. BW is expressed in g
GAR Gestational age at recruitment
* < 0.05; ** < 0.01; *** < 0.0001
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BW. In a Swedish cross-sectional study of 254 mother-
babies, PBDE levels in breast milk were associated with a
decrease in BW specifically in male infants [16]. In Spain,
Lopez-Espinosa et al. reported a negative significant asso-
ciation between BDE-99 and BW [15]. In other five stud-
ies, there was no association [19, 20], statistically not
significant association [18], or a positive association in
female only [21], or the number of subjects was too small
to conclude (n = 20, [17]).
The discrepancy among the results may be explained
by the different designs of the studies, exposures levels,
statistical analyses, adjustments methods, but also by the
presence of underlying predisposing or susceptibility risk
factors in a given population. An important aspect is
that BW is a proxy for in utero growth, a multi-factorial
phenomenon. Indeed, BW is influenced by multiple
factors. These factors do not all have the same degree of
influence and can interact synergistically or not, giving
a multitude of possibilities [43]. This implies that the
link between PBDEs and BW in two homogeneous (so-
cially and/or genetically) populations with two different
combinations of BW-related factors may not be the
same. This theory was well explained by Rothman in
2005 [44]. He suggests that in multifactorial conditions,
several causal components act in concert. A condition
can be caused by different sets of combinations in dif-
ferent individuals or populations. Thus, it is possible
that in our population, PBDEs have little or no role in
determining BW, given the roles of genetic background,
social environment, and complex interactions among
these factors. Thus, our negative finding cannot exclude
that PBDEs can affect populations with different social
and/or genetic backgrounds.
For example, PBDE levels in the Californian study men-
tioned above were similar to those in our population [13]
(Table 5). This study reported a negative association be-
tween PBDE levels in mid-pregnancy and BW in pregnant
women from prenatal care clinics serving low-income res-
idents who qualified for low-income health insurance
(Medicaid). The majority (95 %) are Hispanic, while in our
study, pregnant women were predominantly Caucasian
Canadians (96.5 %) and had substantially higher socio-
Table 4 Association between birth weight corrected for gestational age and maternal plasma levels of PBDEs (log10) in early
pregnancy
Log10 PBDEs Simple linear regressions
a Multivariate linear regressionb
Model A Model B
β 95 % CI β 95 % CI β 95 % CI
Log10 PBDEs (ng/g of lipid)
BDE-47 0.8 −93.1; 94.7 −25.1 −120.4; 70.3 −14.4 −129.9; 101.2
BDE-99 33.7 −34.8; 102.2 20.6 −49.1; 90.4 −1.6 −90.9; 87.7
BDE-100 25.4 −32.5; 83.3 23.9 −33.6; 81.5 4.7 −67.2; 76.5
BDE-153 −49.6 −100.9; 1.7 −40.7 −91.9; 10.6 −55.9 −118.9; 6.9
ΣPBDEs −25.4 −128.7; 77.9 −46.1 −151.3; 59.1 −44.7 −173.6; 84.1
Log10 PBDEs (ng/ml)
c
BDE-47 13.6 −82.7; 109.9 −16.1 −113.5; 81.3 3.0 −115.9; 121.9
BDE-99 46.7 −27.1; 120.5 30.1 −45.2; 105.4 10.2 −86.7; 107.1
BDE-100 30.7 −27.8; 89.2 27.9 −30.1; 85.9 11.6 −61.0; 84.2
BDE-153 −49.7 −103.1; 3.7 −39.6 −103.0; 23.8 −55.0 −120.6; 10.6
ΣPBDEs −12.3 −123.2; 98.5 −39.2 −151.7; 73.3 −27.0 −166.1; 112.0
Log10 PBDEs (ng/ml) adjusted for total plasma lipids.
BDE-47 14.5 −81.8; 110.8 −16.2 −113.6; 81.2 6.5 −112.3; 125.4
BDE-99 70.4 −8.6; 149.4 48.4 −32.3; 129.2 42.1 −63.7; 147.9
BDE-100 31.1 −27.4; 89.6 27.9 −30.1; 85.8 12.8 −59.7; 85.4
BDE-153 −45.4 −100.4; 9.6 −37.5 −92.2; 17.2 −47.1 −115.3; 21.1
ΣPBDEs −2.6 −114.9; 109.7 −32.8 −146.5; 80.9 −9.3 −151.3; 132.6
Abbreviations: CI confidence interval, PBDE(s) Polybrominated diphenyl ether(s), ΣPBDE sum of BDE-47, 99, 100 and 153
aNon-adjusted for potential confounders
bAdjusted for potential confounders
Model A: Adjusted on mother’s age at delivery, marital status, BMI at recruitment, infection, smoking status during pregnancy, ΣPCBs (CB-138, CB-153 and CB-180
expressed in ng/g of lipid), mothers total blood levels of lead (ng/ml)
Model B: Model A + previous pregnancies history (preterm infant and low birth weight infant) in multipara only (N = 234)
cTotal lipids were not taken into account in these models
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Table 5 Medians of PBDE levels (ng/g lipid) in studies which reported the association between birth weight and PBDEs
Country (ref) N Year (s) Specimen analyzed BDE-47 BDE-99 BDE-100 BDE-153 Covariates Association birth weight/PBDEsa
Sweden (24) 254 1996 - 2010 Breast milk 1.30 0.26 0.25 0.54 Di-ortho PCB, gestational length, moternal
age, pre-pregnancy BMI, weight gain during
pregnancy, education, smoking and infant sex.
Negative
California, USA
(21)
286 1999 - 2000 Maternal serum (2nd trimester
of pregnancy)
14.57 3.85 2.45 2.03 Moternal age, marital status, parity, body mass
index, country of birth (United States vs. other),
family income, sex of infant
Negative
Taiwana (25) 20 2000 - 2001 Breast milk 1.52 0.51 0.37 0.87 Maternal age, pre-pregnancy BMI and parity. BDE-47 geometric mean was higher for
birth weight≤ 3.05 Kg compared to birth
weight > 3.05 Kg
Indiana, USA (5) 15 2001 Maternal serum (delivery) 28.00 5.70 4.20 2.90 - No association
Ontario, Canada
(22)
97 2004 - 2005 Maternal serum (24–28 WOA) 24.20 8.73 3.25 4.15 BMI, maternal age, parity, gestational age at
birth, socio-economic status (family income
and years of education), sex of the baby, and
serum cotinine concentration.
Negative only for BDE-99
Australia (26) 150 2008 - 2011 Maternal plasma (38 WOA) 3.96 0.88 0.98 2.26 Maternal age, number of children, Gestational
age, gender, Maternal BMI prior to pregnancy,
maternal weight gain.
Negative not statistically significant
China (28) 215 2010 - 2012 Maternal serum (during
pregnancy)
2.26 3.58 2.13 4.87 Maternal age, parity, education, pre-pregnancy
BMI, weight gain during pregnancy, family
income, gestational age
Positive association with PBDE-153 (in
female infants only)
Spain (23) 473 2003 - 2008 Maternal serum (10–13 WOA) < LOD 1.14 - 2.19 Negative only for BDE-99
486 Umbilical cord blood 1.73 1.05 - 1.91 -
North Carolina,
USA (27)
137 2005 - 2008 Maternal serum (35–36 WOA) 18.87 5.5 4.61 5.65 Final models not show No association
Our study 349 2007 - 2008 Maternal serum (<29 WOA) 20.93 4.03 2.21 4.21 Maternal age, marital status, BMI, infection,
smoking status, PCBs, lead (ng/ml), plus
previous pregnancies history (preterm
infant and low birth weight infant) in
multipara only (N = 234).
No association
aMean
WOA Weeks of amenorrhea
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economic status (median family income was CAD$60,000).
Because BW is strongly linked to lifestyle (nutritional sta-
tus, social stress and maternal health), this difference
between these two populations could explain the mismatch
of our results, either through a synergistic relation between
socioeconomic status and PBDEs, or through residual con-
founding. This emphasizes the importance of choosing a
pertinent set of adjustment variables to assess the relation-
ship between BW and PBDEs.
The Ontario study [14] reported a statistically signifi-
cant negative correlation between BDE-99 and BW in a
group of 97 women. Their study group was also mainly
Caucasian (87 %), but older compared to ours (33 versus
29 years), and much more educated (84.5 % reported
obtaining a university degree or greater versus 33 % in
our data) and fewer were cigarette smokers (7 % versus
19 % in our population). The median levels of three
PBDEs (−47, −100, and −153) in the Ontario study were
similar to those in our population. However, the median
level of congener BDE-99, for which they report a nega-
tive correlation with BW, is two-fold higher than in our
study group. Although this may be due to inter-laboratory
differences in analyses, but we cannot exclude that the
Ontario study has a different exposure profile. Another
limitation of the Ontario study is the small size of the
study group and thus a limited statistical power to reliably
affirm the decrease of 2 grams of BW per one ng/g lipids
of BDE-99.
Lignell et al. [16] also found a significant negative rela-
tion between BW and the sum of PBDEs levels (BDE-47,
BDE-99, BDE-100, BDE-153) measured in breast milk
from 254 mothers in Sweden. These women were rela-
tively close to our study group in terms of maternal age
and education. They report that the association between
PBDEs and BW was significant only after adjustment for
di-ortho-PCBs (the same we considered in our analyses).
However, it is important to note that the design of their
study including retrospective exposure assessment (PBDEs
in breast milk 3 weeks after delivery) as well as very low
levels of PBDEs and narrow range of exposures (for ex-
ample, the maximum level of BDE-153 in breast milk in
our population was 180 ng/g lipids [16] versus 4.7 ng/g
lipids in Lignell et al.’ study) are significant limitations for
the comparison with our study.
In the Spanish study [15], which was one of the largest
among available studies, only one PBDE congener (BDE-
99) was significantly and negatively correlated with BW.
The study group of the Spanish study was very different
from our study group in terms of smoking rate (32 %
versus 19 %), education level (24 % with primary educa-
tional level versus 3 % in our study), and PBDE exposure
(high proportion of values below LOD). Although they
reported that their database contains a large number of
variables which are potential confounders, we could not
identify to which confounders they adjusted their final
models. In addition, it is not clear at which moment of
pregnancy blood was taken for PBDE levels. This miss-
ing information limits the comparison with our study.
Interestingly, we recently reported a negative correlation
between PBDE levels in early pregnancy and thyroxin
levels in cord blood within the same population [6]. How-
ever, BW was not correlated with thyroid hormones
measured in early pregnancy or in cord blood (data not
shown) and the inclusion of thyroid hormones in our
models did not change any statistical relationship between
PBDEs and BW (data not shown). Thus, the lack of asso-
ciation between PBDEs and BW should not be construed
as suggesting that PBDEs are safe during fetal develop-
ment. Indeed, several human and experimental studies
suggest a causal link between prenatal exposure to PBDEs
and attention deficit [45]. Even if several contaminants,
including endocrine disrupting chemicals, have been re-
ported to be correlated with BW [13, 14, 16, 25–30], BW
is a weakly sensitive or reliable proxy for developmental
toxicity of environmental pollutants in humans [43], as
shown in our low risk population. Conversely, PBDEs may
affect brain development without any association with
BW by disrupting thyroid hormones during the fetal
period.
Conclusions
Our prospectively collected data indicates that the link
between PBDEs and BW does not exist, is very weak, or
depends on the presence of other risk factors. However,
this does not exclude the possibility of developmental
PBDE toxicity via endocrine disruption.
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between predicted BW (obtained with proc LOESS) and gestational
age at birth. (DOCX 84 kb)
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